Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, mometasone furoate (Nasonex®) cannot be endorsed for use within NHS Wales for use in children aged 3 to 6 years to treat the symptoms of seasonal allergic or perennial rhinitis. |
||
|
||
Medicine details |
||
| Medicine name | mometasone furoate (Nasonex®) | |
| Formulation | 50 micrograms/actuation nasal spray | |
| Reference number | 2894 | |
| Indication | For use in children aged 3 to 6 years to treat the symptoms of seasonal allergic or perennial rhinitis. |
|
| Company | Merck Sharp & Dohme Ltd | |
| BNF chapter | Ear, nose & oropharynx | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Ratification by Welsh Government | 09/12/2015 | |
| Date of issue | 10/12/2015 | |